DTCFF
Price
$0.60
Change
+$0.06 (+11.11%)
Updated
Dec 24 closing price
Capitalization
31.19M
Intraday BUY SELL Signals
MOLN
Price
$4.34
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Capitalization
162.64M
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DTCFF vs MOLN

Header iconDTCFF vs MOLN Comparison
Open Charts DTCFF vs MOLNBanner chart's image
DEFENCE THERAPEUTICS
Price$0.60
Change+$0.06 (+11.11%)
Volume$4.81K
Capitalization31.19M
Molecular Partners AG
Price$4.34
Change-$0.00 (-0.00%)
Volume$147
Capitalization162.64M
DTCFF vs MOLN Comparison Chart in %
DTCFF
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
DTCFF vs. MOLN commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTCFF is a Hold and MOLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (DTCFF: $0.60 vs. MOLN: $4.34)
Brand notoriety: DTCFF and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTCFF: 12% vs. MOLN: 2%
Market capitalization -- DTCFF: $31.19M vs. MOLN: $162.64M
DTCFF [@Biotechnology] is valued at $31.19M. MOLN’s [@Biotechnology] market capitalization is $162.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTCFF’s FA Score shows that 0 FA rating(s) are green whileMOLN’s FA Score has 0 green FA rating(s).

  • DTCFF’s FA Score: 0 green, 5 red.
  • MOLN’s FA Score: 0 green, 5 red.
According to our system of comparison, MOLN is a better buy in the long-term than DTCFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTCFF’s TA Score shows that 5 TA indicator(s) are bullish while MOLN’s TA Score has 3 bullish TA indicator(s).

  • DTCFF’s TA Score: 5 bullish, 4 bearish.
  • MOLN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, DTCFF is a better buy in the short-term than MOLN.

Price Growth

DTCFF (@Biotechnology) experienced а +7.14% price change this week, while MOLN (@Biotechnology) price change was +2.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

MOLN is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($163M) has a higher market cap than DTCFF($31.2M). DTCFF YTD gains are higher at: 53.802 vs. MOLN (-8.593). DTCFF has higher annual earnings (EBITDA): -3.25M vs. MOLN (-58.01M). MOLN has more cash in the bank: 105M vs. DTCFF (2.32M). MOLN has less debt than DTCFF: MOLN (1.53M) vs DTCFF (2.97M). DTCFF (0) and MOLN (0) have equivalent revenues.
DTCFFMOLNDTCFF / MOLN
Capitalization31.2M163M19%
EBITDA-3.25M-58.01M6%
Gain YTD53.802-8.593-626%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.32M105M2%
Total Debt2.97M1.53M194%
TECHNICAL ANALYSIS
Technical Analysis
DTCFFMOLN
RSI
ODDS (%)
Bullish Trend 3 days ago
60%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
54%
Bearish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
66%
Bearish Trend 3 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
71%
Advances
ODDS (%)
Bullish Trend 24 days ago
62%
Bullish Trend 5 days ago
68%
Declines
ODDS (%)
Bearish Trend 8 days ago
58%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DTCFF
Daily Signal:
Gain/Loss:
MOLN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SRCRF0.270.01
+2.43%
Scorpio Gold Corp.
EPOAY22.520.05
+0.22%
Epiroc Aktiebolag
BDVSF13.45N/A
N/A
Bidvest Group Ltd.
JNDOF22.75N/A
N/A
Jins Hldgs Inc.
LCHD0.02N/A
N/A
Leader Capital Holdings Corp.

DTCFF and

Correlation & Price change

A.I.dvisor tells us that DTCFF and VERA have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DTCFF and VERA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTCFF
1D Price
Change %
DTCFF100%
+10.35%
VERA - DTCFF
14%
Poorly correlated
+3.26%
BRNS - DTCFF
11%
Poorly correlated
-1.07%
MOLN - DTCFF
7%
Poorly correlated
N/A
VALN - DTCFF
6%
Poorly correlated
+1.50%
LYEL - DTCFF
5%
Poorly correlated
+3.40%
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
N/A
SNSE - MOLN
39%
Loosely correlated
+0.54%
SLDB - MOLN
36%
Loosely correlated
N/A
RCKT - MOLN
33%
Poorly correlated
+1.74%
ATRA - MOLN
31%
Poorly correlated
+0.51%
RAPT - MOLN
30%
Poorly correlated
+1.24%
More